Genotype and phenotype in Klinefelter syndrome - impact of androgen receptor polymorphism and skewed X inactivation

International Journal of Andrology

Volumn 34, Issue 6 PART 2, 2011, Pages

  Bojesen, A ^a   Hertz, J M ^b   Gravholt, C H ^b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Androgen receptor polymorphism; Klinefelter syndrome; Skewed X inactivation; X chromosome inactivation

Indexed keywords

ADIPONECTIN; ANDROGEN RECEPTOR; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESTEROLONE; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BONE DENSITY; CAG REPEAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HIP; HOMOZYGOTE; HUMAN; KARYOTYPE 46,XY; KARYOTYPE 47,XXY; KLINEFELTER SYNDROME; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINE; TRIACYLGLYCEROL BLOOD LEVEL; X CHROMOSOME INACTIVATION;

GENOTYPE; HUMANS; KLINEFELTER SYNDROME; PHENOTYPE; PROMOTER REGIONS, GENETIC; RECEPTORS, ANDROGEN; X CHROMOSOME INACTIVATION;

EID: 81455139505     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01223.x     Document Type: Article

References (33)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM & Belmont JW. (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51, 1229-1239.
2. Berletch JB, Yang F & Disteche CM. (2010) Escape from X inactivation in mice and humans. Genome Biol 11, 213.
3. Bojesen A & Gravholt CH. (2007) Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 4, 192-204.
4. Bojesen A, Juul S & Gravholt CH. (2003) Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 88, 622-626.
5. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P et al. (2006) The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29, 1591-1598.
6. Bojesen A, Birkebaek N, Kristensen K, Heickendorff L, Mosekilde L, Christiansen JS & Gravholt CH. (2011) Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 22, 1441-1450.
7. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M & Gilliland DG. (1996) Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 88, 59-65.
8. Busque L, Paquette Y, Provost S, Roy DC, Levine RL, Mollica L & Gilliland DG. (2009) Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies. Blood 113, 3472-3474.
9. Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di MA, Selice R, Lenzi A & Foresta C. (2011) Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96, E739-E745.
10. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH & Kantoff PW. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94, 3320-3323.
11. Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC & Kantoff PW. (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53, 121-125.
12. Hickey T, Chandy A & Norman RJ. (2002) The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 87, 161-165.
13. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O'Neill TW, Platt H et al. (2009) Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94, 277-284.
14. Iitsuka Y, Bock A, Nguyen DD, Samango-Sprouse CA, Simpson JL & Bischoff FZ. (2001) Evidence of skewed X-chromosome inactivation in 47, XXY and 48, XXYY Klinefelter patients. Am J Med Genet 98, 25-31.
15. La Spada AR, Wilson EM, Lubahn DB, Harding AE & Fischbeck KH. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79.
16. Lanfranco F, Kamischke A, Zitzmann M & Nieschlag E. (2004) Klinefelter's syndrome. Lancet 364, 273-283.
17. Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL & Eriksen EF. (2003) A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 73, 237-243.
18. Mohlig M, Arafat AM, Osterhoff M, Isken F, Weickert M, Spranger J, Pfeiffer A & Schofl C. (2011) Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men. Eur J Endocrinol 164, 1013-1018.
19. Nenonen H, Bjork C, Skjaerpe PA, Giwercman A, Rylander L, Svartberg J & Giwercman YL. (2010) CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 16, 153-157.
20. Nielsen J & Wohlert M. (1990) Sex chromosome abnormalities found among 34, 910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser 26, 209-223.
21. Page ST, Kupelian V, Bremner WJ & McKinlay JB. (2006) The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65, 333-339.
22. Ratcliffe S. (1999) Long-term outcome in children of sex chromosome abnormalities. Arch Dis Child 80, 192-195.
23. Ross NL, Wadekar R, Lopes A, Dagnall A, Close J, DeLisi LE & Crow TJ. (2006) Methylation of two Homo sapiens-specific X-Y homologous genes in Klinefelter's syndrome (XXY). Am J Med Genet B Neuropsychiatr Genet 141B, 544-548.
24. Stanworth RD, Kapoor D, Channer KS & Jones TH. (2008) Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol 159, 739-746.
25. Stiger F, Brandstrom H, Gillberg P, Melhus H, Wolk A, Michaelsson K & Kindmark A. (2008) Association between repeat length of exon 1 CAG microsatellite in the androgen receptor and bone density in men is modulated by sex hormone levels. Calcif Tissue Int 82, 427-435.
26. Thouin MM, Giron JM & Hoffman EP. (2003) Detection of nonrandom X chromosome inactivation. Curr Protoc Hum Genet, 9.7.1-9.7.6.
27. Wikstrom AM, Painter JN, Raivio T, Aittomaki K & Dunkel L. (2006) Genetic features of the X chromosome affect pubertal development and testicular degeneration in adolescent boys with Klinefelter syndrome. Clin Endocrinol (Oxf) 65, 92-97.
28. Zeegers MP, Kiemeney LA, Nieder AM & Ostrer H. (2004) How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13, 1765-1771.
29. Zeger MP, Zinn AR, Lahlou N, Ramos P, Kowal K, Samango-Sprouse C & Ross JL. (2008) Effect of ascertainment and genetic features on the phenotype of Klinefelter syndrome. J Pediatr 152, 716-722.
30. Zinn AR, Ramos P, Elder FF, Kowal K, Samango-Sprouse C & Ross JL. (2005) Androgen receptor CAGn repeat length influences phenotype of 47, XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 90, 5041-5046.
31. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R & Nieschlag E. (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55, 649-657.
32. Zitzmann M, Gromoll J, von Eckardstein A & Nieschlag E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46, 31-39.
33. Zitzmann M, Depenbusch M, Gromoll J & Nieschlag E. (2004) X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in klinefelter patients. J Clin Endocrinol Metab 89, 6208-6217.